The effect of real oat bread with barley bread on serum glucose and lipid Levels in dyslipidemia and type II diabetes

Phase 2

• Conditions: Condition 1: Diabetes. Condition 2: Dyslipidemia.; Non-insulin-dependent diabetes mellitus, Malnutrition-related diabetes mellitus; Pure hypercholesterolaemia, Other hyperlipidaemia, Hyperlipidaemia, unspecified, Lipoprotein deficiency, Other disorders of lipoprotein metabolism, Disorder of lipoprotein metabolism, unspecified; E11, E12; E708.0,E78

• Registration Number: IRCT138711071597N1
• Lead Sponsor: ational Nutrition & Food Technology Research Institute of IRA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients with Fasting blood glucose > 126 mg/dl and at least one of lipids profile out of normal range
Exclusion criteria: Patients with Cardiovascular and other systemic diseases and IDMM patients taking insulin

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum glucose levels. Timepoint: 0, 10 days after intervention. Method of measurement: Taking 5 ml fasting venous blood sample, Centrifuging samples, determining serum glucose by glucose oxidase using Auto analyzer.;Serum insuline levels. Timepoint: 0, 10 days after intervention. Method of measurement: Taking 5 ml fasting venous blood sample, Centrifuging samples, determining serum Insulin levels using Radioimmunoassay.

Secondary Outcome Measures

Name	Time	Method
Fasting serum insulin levels. Timepoint: 0, 10, 21 days after intervention. Method of measurement: Taking 5 ml fasting venous blood sample, Centrifuging samples, determining serum Insulin levels using Radioimmunoassay.;Serum lipid profiles. Timepoint: 0, 10, 21 days after intervention. Method of measurement: Taking 5 ml fasting venous blood sample, Centrifuging samples, determining serum lipid profiles using Auto analyzer.;Insulin resistance. Timepoint: 0, 10, 21 days after intervention. Method of measurement: Computing insulin resistance using HOMA: (FBS*FIns)/22.5.